A look behind the scenes: the risk and pathogenesis of primary osteoporosis

被引:224
作者
Hendrickx, Gretl [1 ]
Boudin, Eveline [1 ]
Van Hul, Wim [1 ]
机构
[1] Univ Antwerp, Dept Med Genet, B-2650 Edegem, Belgium
关键词
BONE-MINERAL DENSITY; GENOME-WIDE ASSOCIATION; ESTROGEN-RECEPTOR-ALPHA; GROWTH-FACTOR-BETA; OXIDATIVE STRESS; OSTEOGENESIS IMPERFECTA; POSTMENOPAUSAL WOMEN; ANDROGEN RECEPTOR; BRUCK SYNDROME; GENETIC-DETERMINANTS;
D O I
10.1038/nrrheum.2015.48
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporosis is a common disorder, affecting hundreds of millions of people worldwide, and characterized by decreased bone mineral density and increased fracture risk. Known nonheritable risk factors for primary osteoporosis include advanced age, sex-steroid deficiency and increased oxidative stress. Age is a nonmodifiable risk factor, but the influence of a person's lifestyle (diet and physical activity) on their bone structure and density is modifiable to some extent. Heritable factors influencing bone fragility can be monogenic or polygenic. Osteogenesis imperfecta, juvenile osteoporosis and syndromes of decreased bone density are discussed as examples of monogenic disorders associated with bone fragility. So far, the factors associated with polygenic osteoporosis have been investigated mainly in genome-wide association studies. However, epigenetic mechanisms also contribute to the heritability of polygenic osteoporosis. Identification of these heritable and nonheritable risk factors has already led to the discovery of therapeutic targets for osteoporosis, which emphasizes the importance of research into the pathogenetic mechanisms of osteoporosis. Accordingly, this article discusses the many heritable and nonheritable factors that contribute to the pathogenesis of primary osteoporosis. Although osteoporosis can also develop secondary to many other diseases or their treatment, a discussion of the factors that contribute only to secondary osteoporosis is beyond the scope of this Review.
引用
收藏
页码:462 / 474
页数:13
相关论文
共 150 条
[41]   Osteoporosis Caused by Mutations in PLS3: Clinical and Bone Tissue Characteristics [J].
Fahiminiya, Somayyeh ;
Majewski, Jacek ;
Al-Jallad, Hadil ;
Moffatt, Pierre ;
Mort, John ;
Glorieux, Francis H. ;
Roschger, Paul ;
Klaushofer, Klaus ;
Rauch, Frank .
JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (08) :1805-1814
[42]   Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density [J].
Fahiminiya, Somayyeh ;
Majewski, Jacek ;
Roughley, Peter ;
Roschger, Paul ;
Klaushofer, Klaus ;
Rauch, Frank .
BONE, 2013, 57 (01) :41-46
[43]   Sclerosing Bone Dysplasias: Leads Toward Novel Osteoporosis Treatments [J].
Fijalkowski, Igor ;
Boudin, Eveline ;
Mortier, Geert ;
Van Hul, Wim .
CURRENT OSTEOPOROSIS REPORTS, 2014, 12 (03) :243-251
[44]   MICROPETROSIS [J].
FROST, HM .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1960, 42 (01) :144-150
[45]   MicroRNAs and post-transcriptional regulation of skeletal development [J].
Gamez, Beatriz ;
Rodriguez-Carballo, Edgardo ;
Ventura, Francesc .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2014, 52 (03) :R179-R197
[46]  
Garnero Patrick, 2012, Bonekey Rep, V1, P182, DOI 10.1038/bonekey.2012.182
[47]   Increased cell surface expression of receptors for transforming growth factor-β on osteoblasts from patients with osteogenesis imperfecta [J].
Gebken, J ;
Brenner, R ;
Feydt, A ;
Notbohm, H ;
Brinckmann, J ;
Müller, PK ;
Bätge, B .
PATHOBIOLOGY, 2000, 68 (03) :106-112
[48]   Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency [J].
Gelb, BD ;
Shi, GP ;
Chapman, HA ;
Desnick, RJ .
SCIENCE, 1996, 273 (5279) :1236-1238
[49]   Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis [J].
Giorgio, M ;
Migliaccio, E ;
Orsini, F ;
Paolucci, D ;
Moroni, M ;
Contursi, C ;
Pelliccia, G ;
Luzi, L ;
Minucci, S ;
Marcaccio, M ;
Pinton, P ;
Rizzuto, R ;
Bernardi, P ;
Paolucci, F ;
Pelicci, PG .
CELL, 2005, 122 (02) :221-233
[50]   LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development [J].
Gong, YQ ;
Slee, RB ;
Fukai, N ;
Rawadi, G ;
Roman-Roman, S ;
Reginato, AM ;
Wang, HW ;
Cundy, T ;
Glorieux, FH ;
Lev, D ;
Zacharin, M ;
Oexle, K ;
Marcelino, J ;
Suwairi, W ;
Heeger, S ;
Sabatakos, G ;
Apte, S ;
Adkins, WN ;
Allgrove, J ;
Arslan-Kirchner, M ;
Batch, JA ;
Beighton, P ;
Black, GCM ;
Boles, RG ;
Boon, LM ;
Borrone, C ;
Brunner, HG ;
Carle, GF ;
Dallapiccola, B ;
De Paepe, A ;
Floege, B ;
Halfhide, ML ;
Hall, B ;
Hennekam, RC ;
Hirose, T ;
Jans, A ;
Jüppner, H ;
Kim, CA ;
Keppler-Noreuil, K ;
Kohlschuetter, A ;
LaCombe, D ;
Lambert, M ;
Lemyre, E ;
Letteboer, T ;
Peltonen, L ;
Ramesar, RS ;
Romanengo, M ;
Somer, H ;
Steichen-Gersdorf, E ;
Steinmann, B .
CELL, 2001, 107 (04) :513-523